The safety of incretin based drugs

Affiliations

Editorial

Victor M Montori. BMJ. 2014.

. 2014 Apr 24:348:g2779.

doi: 10.1136/bmj.g2779.

¹ Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA.

No abstract available

Comment on

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies.
Li L, Shen J, Bala MM, Busse JW, Ebrahim S, Vandvik PO, Rios LP, Malaga G, Wong E, Sohani Z, Guyatt GH, Sun X. Li L, et al. BMJ. 2014 Apr 15;348:g2366. doi: 10.1136/bmj.g2366. BMJ. 2014. PMID: 24736555 Free PMC article.
Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study.
Faillie JL, Azoulay L, Patenaude V, Hillaire-Buys D, Suissa S. Faillie JL, et al. BMJ. 2014 Apr 24;348:g2780. doi: 10.1136/bmj.g2780. BMJ. 2014. PMID: 24764569 Free PMC article.